We design recombinant monoclonal antibodies for research targets not currently in our catalog—built on the same platform as our IHC-validated RUO antibodies.
Choose our custom service if your project involves:
Provide details on your target, desired domain, intended application (e.g., IHC), and available antigen or tissue context.
We assess platform compatibility, domain accessibility, sequence space, and potential IP restrictions. Note: Some assessments may require a feasibility fee, credited toward project development.
If feasible, we initiate custom development using our validated pipeline. You receive the final antibody along with IHC and ELISA validation data (as agreed).
We can supply the antibody as a RUO product or offer limited exclusivity agreements depending on project scope.
All custom antibodies are:
Newsletter
Subscribe to our newsletter for exclusive updates on new domain-specific antibodies, validation data, and application insights. Be the first to learn about product launches, service offers, and the latest findings in translational and therapeutic research—delivered straight to your inbox.
